Answers are grounded in this paper and cite their sources.
Artificial intelligence (AI) is designed to mimic human intelligence in machines. The growth of information technology and advancement in the computing power of computers provided a great platform for progress in many pharmaceutical industry and healthcare sectors. Leading to the consolidation of the pharmaceutical, and healthcare industries with AI companies. AI is used in various departments of the pharmaceutical sector such as drug discovery, development, target identification, manufacturing process, dosage design, clinical trial design, and many more. There are several challenges and limitations of AI that must be addressed by the pharmaceutical industry before its adoption and successful integration into various processes. The present article is focused on Artificial Neural Networks in the pharmaceutical sector, Drug design and discovery, drug repurposing, research and development, pharmaceutical product development, manufacturing process, quality assurance and quality controls, and some challenges and prospects of AI. • AI mimics human intelligence in machines. • Integrated use of AI in the pharmaceutical healthcare sector. • Applications, challenges, and limitations of AI in the pharma industry. • AI Integration may help ensure the safety and efficacy of the products.
No takes yet. Share an insight, caveat, or question.
Bhat et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: